Global Clinical Trial Supplies Market By 2018-2025| Industry Top Players The Whitewave Foods Company, Kite Hill, Oalty, Blue Diamond Growers, Earth’s Own Food Company Inc., Sunopta, Pureharvest, Pacific Foods Of Oregon, Inc.

This comprehensive Global Clinical Trial Supplies Market industry research report includes a brief on these trends that can help the organizations operating in the industry to understand the market and strategize for their business expansion accordingly. The research report analyzes the market CAGR, Volume, industry share And size, demand and trend growth, key segments, and key drivers and restrains.

Market Trends:

  • On the basis of Services, the market is segmented into Storage, Manufacturing, Packaging and Labeling, Distribution.
  • On the basis of Clinical Phase, the market is segmented into Phase III, Phase II, Phase IV, Phase I. In 2018, Phase III segment is growing at the highest CAGR and expected to reach USD in the forecast period of 2018 to 2025

Get A Free Sample Report Now @

Major Players: Global Clinical Trial Supplies Market

Some of the prominent participants operating in this market are

  • Movianto,
  • Sharp,
  • Thermo Fisher Scientific Inc.,
  • Catalent, Inc,
  • PCI Pharma Services,
  • Almac Group,
  • PAREXEL International Corporation,
  • Bionical Ltd.,
  • Alium Medical Limited,
  • Clinigen Group plc,
  • Ancillare,
  • LP ,
  • SIRO Clinpharm,
  • Biocair
  • And among others.


Global Clinical Trial Supplies Market is expected to reach million by 2025 and is projected to register a healthy CAGR of 7.8% in the forecast period of 2018 to 2025.

Drivers: Global Clinical Trial Supplies Market


The burden of chronic diseases is rapidly increasing worldwide. This is because of increase in population on globe. These diseases are playing important role in clinical trial field in development of drugs. Any drug to be available in market requires clinical trial which helps in approval of the drugs by regulatory bodies.

According to National Institutes of Health (NIH), 57.0% of new cancer cases in 2012 found in developing regions of the world that include central America, some parts of Africa as well as Asia; 65.0% of deaths due to cancer also found in these regions

To know more please Request an Analyst Call or can drop down your inquiry… @


The pharmaceutical industries are under serious pressure in recent time to provide drugs world widely because of wide range of diseases are occurring. North America, Europe and Asia especially in Japan in combination account for 82.0% of total drug sales on globe. These drugs are available in the market after clinical trials. So all the companies mostly carries clinical trial accordingly depending upon the type of drug or device machine

The leaders in clinical trial supplies market include a mix of organizations. These are not just clinical service providers but also involved in the new drug development process, and they are Paraxel International Corporation (U.S.), IQVIA (U.S.), Medpace Holdings, Inc, (U.S.), Charles River Laboratories International Inc (CRL) (U.S.) and many other.

Global Clinical Trial Supplies Market



Adverse drug reactions are the unwanted or harmful effects which are experienced after the administration of a drug under normal conditions of use in humans.

Adverse drug reactions may be in form of rashes, jaundice, anaemia, and decrease in the white blood cell count, kidney damage, and nerve injury that may lead to impaired vision or hearing.

In April 2013, the news published in the times of India (India), 2,644 died during clinical trial of drugs in 7 years.



Clinical trials provide a base for new drug development processes, as well as for product license extensions for existing therapies. Over the past period, there has been a dramatic rise in the number of registered clinical trials.

Clinical trials provide a base for new drug development processes, as well as for product license extensions for existing therapies. Over the past period, there has been a dramatic rise in the number of registered clinical trials.

One of the developing countries, Africa is emerging as an important destination in performing clinical trial. In the year 2013 alone, 4,060 clinical trials were conducted with major pharmaceutical companies have their presence in Africa.

Read More Detailed and Analyzed Content on our Report Page @



Clinical trial process helps in development of new drugs or medical devices which is used for treatment of various diseases such as cardiovascular diseases, cancer, respiratory diseases and many more.

These drugs or medical devices are developed in various at CROs where scientists perform development test for number of times in labs and followed by pre-clinical trials which take some months or several years to get approval from authorized organizations.

Unfortunately, the process of developing a biologic drug is extremely risky, time consuming, and expensive. In fact, the vast majority of biologic medicines never make it to data exclusivity protects the actual investment needed to prove the safety and efficacy of a biopharmaceutical product.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us-

Data Bridge Market Research

US: +1-888-387-2818

Email: [email protected]

Posted by on Friday January 18 2019, 11:15 AM EDT. All trademarks acknowledged. Filed under Featured Press Release, Healthcare. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in